West Pharmaceutical Services, Inc. (WST) is a global healthcare company specializing in containment and delivery systems for injectable drugs. With a market cap of $19.2 billion, it offers elastomeric components, syringe parts, drug delivery devices, and analytical services. Despite being a large-cap stock, WST has seen a 23.6% drop from its 52-week high of $348.90. Over the past year, its shares have declined by 19.4%, underperforming the Health Care Select Sector SPDR Fund. Investor concerns about operational challenges and pricing headwinds have impacted WST’s performance, lagging behind competitors like Thermo Fisher Scientific Inc. However, analysts still rate it as a “Strong Buy” with a mean price target of $345.36, indicating a potential upside of 29.6%.

Read more at Yahoo Finance: Is WST Underperforming the Healthcare Sector?